(Total Views: 134)
Posted On: 10/12/2022 8:10:55 AM
Post# of 12
$ALPMY News Article - Astellas to Present Findings from Phase 3 Long-Term Safety Study of Fezolinetant in Oral Session at The North American Menopause Society 2022 Annual Meeting https://marketwirenews.com/news-releases/aste...24107.html
(0)
(0)
My Twitter: WhyteStocks
